Get all your news in one place.
100's of premium titles.
One app.
Start reading
Euronews
Euronews
Giedre Peseckyte

US push to cut drug prices could mean longer waits for European patients

Last May, US President Donald Trump pushed to align drug pricing with the lowest levels among other developed nations — so-called most-favoured-nation (MFN) pricing. However, the pricing policy might have negative consequences.

European patients might have to wait longer for some novel medicines as the US forces drugmakers to offer prices that match those of other high‑income countries, such as Germany or France, according to a new modelling study published in The Lancet.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.